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Background and Aims: Crohn’s Disease (CD), a chronic Inflammatory Bowel Disease,
can occur in any part of the gastrointestinal tract, but most frequently in the ileum.
Visceral hypersensitivity contributes for development of chronic abdominal pain in this
disease. Currently, the understanding of the mechanism underlying hypersensitivity of
Crohn’s ileitis has been hindered by a lack of specific animal model. The present study is
undertaken to investigate the visceral hypersensitivity provoked by 2,4,6-trinitrobenzene
sulfonic (TNBS)-induced ileitis rats.
Methods: Male Sprague-Dawley rats were anaesthetized and laparotomized for
intraileal injection of TNBS (0.6 ml, 80 mg/kg body weight in 30% ethanol, n = 48),
an equal volume of 30% Ethanol (n = 24), and Saline (n = 24), respectively. Visceral
hypersensitivity was assessed by visceromotor responses (VMR) to 20, 40, 60, 80,
and 100 mmHg colorectal distension pressure (CRD) at day 1, 3, 7, 14, 21, and
28. Immediately after CRD test, the rats were euthanized for collecting the terminal
ileal segment for histopathological examinations and ELISA of myleoperoxidase and
cytokines (TNF-α, IL-1β, IL-6), and dorsal root ganglia (T11) for determination of
calcitonin gene-related peptide by immunohistochemistry, respectively.
Results: Among all groups, TNBS-treatment showed transmural inflammation initially
at 3 days, reached maximum at 7 days and persisted up to 21 days. The rats with
ileitis exhibited (P < 0.05) VMR to CRD at day 7 to day 21. The calcitonin gene-related
peptide-immunoreactive positive cells increased (P < 0.05) in dorsal root ganglia at day
7 to 21, which was persistently consistent with visceral hypersensitivity in TNBS-treated
rats.
Conclusion: TNBS injection into the ileum induced transmural ileitis including
granuloma and visceral hypersensitivity. As this model mimics clinical manifestations
of CD, it may provide a road map to probe the pathogenesis of gut inflammation and
visceral hypersensitivity, as well as for establishing the therapeutic protocol for Crohn’s
ileitis.
Keywords: TNBS, cytokines, ileitis, visceral hypersensitivity, visceromotor response, crohn’s disease, calcitonin
gene-related peptide, rat
Abbreviations: CD, Crohn’s disease; CGRP, calcitonin gene-related peptide; CGRP-IR, calcitonin gene-related peptide-
immunoreactive; CRD, colorectal distension; DAI, disease activity index; DRG, dorsal root ganglia; ELISA, enzyme-linked
immunosorbent assay; EMG, electromyography; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; IL-1β,
interleukin-1 beta; IL-6, interleukin-6; MPO, myeloperoxidase; TNBS, 2,4,6-trinitrobenzene sulfonic acid; TNF-α, tumor
necrosis factor-alpha; UC, ulcerative colitis; VH, visceral hypersensitivity; VMR, visceromotor responses.
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INTRODUCTION
Crohn’s disease, a major form of human IBDs, is a
chronic, remitting, and relapsing inflammatory disorder of
gastrointestinal tract that can affect animal and almost all ages
of human population. It leads to a wide range of symptoms,
such as diarrhea, nausea, abdominal pain, and VH, which
has a significant effect on the life quality of affected patients
(Wagtmans et al., 1998; Simren et al., 2002; Faure and Giguere,
2008). In IBD, the continuous release of inflammatory mediators
can result enteric nerve endings sensitization and abdominal
pain in 70% of IBD patients, which is not only present during
acute flares of disease but also during remission (Minderhoud
et al., 2004; Bielefeldt et al., 2009). Two thirds of CD manifest
as a transmural inflammation in the terminal ileum. Whether
CD patients suffer from visceral sensitivity disturbances seem
somewhat controversial, and its evidence is likewise scarce.
Bernstein et al. (1996) discovered that patients with ileal CD
had reduced sensitivity and autonomic reflex responses when
the rectum was distended. However, Faure and Giguere (2008)
reported that CD patients coexisting functional GI disorders on
rectal distension showed an increased rectal hypersensitivity.
The discrepancy regarding VH should be addressed properly
using CD model as a choice to add the knowledge in this filed.
Over the years, most studies have investigated VH utilizing
colitis models (Diop et al., 2002; Zhou et al., 2008; Feng et al.,
2012). However, the colitis could not be appropriate for studying
the precise mechanism of VH accompanying CD because its
location, duration, microbiota and central regulating mechanism
are different from the CD of ileal origin. So far no ileitis model
that provokes VH has been reported.
Experimental models for intestinal inflammations were
commonly induced by TNBS, oxazolone, and dextran sodium
sulfate. Among them, TNBS is diluted in ethanol to disrupt the
mucosal barrier. It invades and causes haptenization of colonic
mucosal proteins (Neurath et al., 2000), and has primarily been
regarded as a model for studying CD and UC (Wallace et al.,
1995; Jurjus et al., 2004). Over the years, few studies used
TNBS to induce ileitis for studying the pathophysiology of ileal
diseases. Nurgali et al. (2011) injected TNBS solution into the
ileal lumen of guinea pigs for studying the morphological and
functional changes in neurons projecting to the ileal mucosa
at the early stage after inflammatory damage. Sjogren et al.
(1994) and Goldhill et al. (1999) used TNBS-induced ileitis for
investigation of in vivo ileal myoelectric responses to acute enteric
inflammations in rabbits and in vitro smooth muscle contractility
in rats. So far as we know, there is no report on VH in ileitis
models.
Crohn’s disease is characterized by the infiltration of
inflammatory and immune cells (e.g., mast cells, neutrophils,
T-lymphocytes, and macrophages) that interact and release
certain enzymes, e.g., MPO and cytokines etc. Intestinal
specimens biopsied from Crohn’s patient have shown a
transmural chronic inflammation with upregulated MPO and
cytokines (e.g., TNF-α, IL-1β, and IL-6) (Ligumsky et al.,
1990; Gross et al., 1992; Reinecker et al., 1993; O’Hara
et al., 2007). These cytokines are believed to result in
neurogenic inflammation (the release of substance-P, CGRP,
and nerve growth factor), which as a consequence influences
neurotransmission, muscle contractility and secretory functions,
and abdominal pain (Collins et al., 1996; Stein et al., 1998).
Cytokines can be used to grade the severity of TNBS-colitis in
rats (Strober and Fuss, 2011; Du et al., 2014). The study by Adam
et al. (2006) looked for the association between the severity of
colitis with the levels of serum IL-6 and VMR, and suggested
inflammatory changes and cytokine levels are responsible for
initiation and maintenance of VH. Therefore, the assessment of
cytokines and CGRP level in ileitis leading to hypersensitivity
seem imperative to understand the pathogenesis of CD as
well as for evaluating the effectiveness of potent therapeutic
agents.
In the present study, to investigate the VH provoked by ileitis,
TNBS/ethanol solution was injected into the terminal ileum in
rats. The DAI, macroscopic and microscopic damage scores,
CGRP level, MPO level, cytokines levels, and VMR to colorectal
distention were assessed to explore the mechanism underlying
VH in ileitis.
MATERIALS AND METHODS
Experimental Animal
Ninety six male Sprague–Dawley rats, aged 5–6 weeks and
weighing 190–289 g, were used for the experiments. The rats
were purchased from Hubei Provincial Center for Experimental
Animal Research, Wuhan, and housed in temperature controlled
room with a 12 h dark–light cycle and provided free access
to standard feed and tap water. The rats were acclimatized
to laboratory environment for 1 week before initiation of the
experiment. All experiments involving live rats were performed
according to the stipulated rules for experimental usage of
laboratory animals (the regulation of the administration of
affairs concerning experimental animals of P.R. China). All
protocols were approved by the Laboratory Animal Research
Center of Hubei province and the ethics committee of Huazhong
Agricultural University (Permit number: HZAUMO-2015-12).
Induction of Ileitis
Rats were randomly assigned for 48 in TNBS group, 24 in ethanol
group and 24 in saline group. After fasted for 24 h, the rats were
anesthetized with Pentobarbital (50 mg/kg body weight, Gbcbio
Technologies Inc., China) intraperitoneally. Following the aseptic
surgical procedure, the midventral laparatomy was performed.
The terminal part of the ileum was exteriorized gently on moist
sterile gauze. The various combinations of TNBS (60–100 mg/kg
body weight, Sigma Aldrich, USA) and ethanol (20–40%) were
tested in our pretest. The dose of TNBS (0.6 ml, 80 mg/kg body
weight in 30% ethanol) was considered suitable to induce the
moderate ileitis according to DAI, macroscopic and microscopic
damage scores, and MPO level. In the formal experiment, 0.6 ml
TNBS (80 mg/kg body weight in 30% Ethanol), an equal volume
of 30% Ethanol and 0.9% NaCl were injected into the rat’s ileal
lumen 10 cm proximal to the ileo-cecal junction for TNBS-,
ethanol- and saline-groups, respectively, using a 30-gauge needle
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fitted to 1 ml syringe. Before injection, a portion of ileum
extending 3.5 cm orad and 3.5 cm aborad to the injection site was
isolated, and milked free of luminal contents. To keep the injected
chemicals to fully contact with the ileal mucosa, the cranial and
caudal sides of the injected ileal fragment were occluded for
5 min with thumb and forefingers with mild pressure (which
just prevented the flow of the injected solution, but not caused
intestinal ischemia judged by its color), and were marked by
tying two fine silk ligatures (5–0) loosely in the mesentery for
later location. Then the ileum was returned to the cavity. The
peritoneum along with linea alba was sutured with catgut 4–0
in simple interrupted pattern. Before the suture of skin, 0.5%
Bupivacaine HCl (Shandong Hualu Pharamaceutical Co. Ltd.,
China) was instilled on the incised wound. Finally, the skin
was sutured using silk 5–0 in simple interrupted pattern. Upon
completion of the surgery, the rats were placed in a rat box.
After recovery from anesthesia, the rats were allowed to access
food and water ad libitum. The operated rats were checked
daily and their wound received pyrrolidone solution (Jiaozuo
Zhongwei Chemical Co., Ltd., China) application twice a day till
healing.
Visceromotor Response to Colorectal
Distension
The VMR to CRD was used as an objective indicator of VH.
The present study used EMG to quantify the magnitude of
the abdominal contractions evoked by CRD. The EMG was
recorded between 8 a.m. and 1 p.m. at day 1, 3, 7, 14, 21, and
28 after the injection as described previously (Winston et al.,
2007). Briefly, the rats were brought to the testing room, and
acclimatized to the testing environment for 3 days. A balloon
(5-cm long) which was constructed with the finger of a latex
glove attached to a flexible tube was inflated and left overnight
to make the latex stretched and the balloon compliant. The
caudal midventral region of the rats were clipped, shaved, and
painted with pyrrolidone solution. The rats were placed in a
plastic cylinder with a sound-attenuating and dark chamber to
limit their movement and allowed to be acclimatized for 30 min
before testing. The flexible balloon was lubricated with paraffin
and inserted 8 cm into the descending colon and rectum via the
anus and held in place by taping the tube to the tail. The tube
of the balloon was connected via a Y-connector to a 20 ml syringe
for inflating balloon and a sphygmomanometer for measuring the
distension pressure. Two thirty-two-gauge nickel-steel needles
(0.25 mm in diameter and 25 mm in length, Suzhou Medical
Supplies, Co. Ltd., China) as EMG electrodes were inserted
via the skin into abdominal muscle, placed 2–3 cm apart just
before CRD and EMG recording. Then both electrodes along
with skin were clamped and connected to the EMG-machine
(Nanjing Medease Science and Technology Co. Ltd., China). The
balloon was inflated every 6 s in a continuous ramp distension
mode (20, 40, 60, 80, and 100 mmHg) and then a 3 min break
was maintained before another set of distension (Figure 1).
The procedure of balloon distension and EMG recordings were
repeated three times. A software (MedLab-U/4C501) was used
to quantify the magnitude of EMG signals and mechanical
irritation signals. VMRs to CRD were quantified as the total
area of electromyographic activity during balloon inflation minus
the resting activity and were presented as millivolt per-second
(mV/s).
Symptoms and Disease Activity Index
Symptoms such as body weight, water/food consumption,
mortality, stool consistency, and bloody feces were observed at
day 0, 1, 3, 7, 14, 21, and 28. The mean body weights at day 0 and
at sampling days were expressed as BW0 and BWn, respectively.
The percentage change in the body weight was calculated as
follows: 1 (%) = (BWn – BW0)/BW0 × 100%. Quantification
of DAI comprised body weight (0–4), stool consistency (0–4)
and rectal bleeding (0–4), and was determined daily between 8
and 10 a.m. as described in detail elsewhere (Cooper et al., 1993;
Siegmund et al., 2001). The scores from these three parameters
were summed up as DAI ranging from 0 (healthy) to 12 (maximal
severity) (Alex et al., 2009).
Tissue Sampling
Sixteen rats taken from the TNBS group (8 rats), the ethanol
group (4 rats) and the saline group (4 rats) at day 1, 3, 7, 14,
21, and 28, respectively, were euthanized immediately after CRD
test. The 10-cm terminal ileum of each rat was excised. After
being washed in phosphated buffer saline solution, two ileal
segments (one 5 mm, another 1 cm long) in sequence were taken
from the distal end of each ileum. The short segment was fixed
in 4% buffered formaldehyde for histopathological examination.
The longer segment was weighted, frozen in liquid nitrogen and
transferred to store at −80◦C for assaying the concentrations of
MPO, TNF-α, IL-1β, and IL-6. The DRG of T11 thoracic (left and
right) enlargement was dissected out properly and post-fixed in
4% buffered formaldehyde for immunohistochemical analysis of
CGRP.
Macroscopic and Microscopic
Observation
The macroscopic appearance was scored by two blinded
investigators on a scale of 0–4, described by Morris et al. (1989).
Ileal tissues fixed in 4% buffered formaldehyde were embedded
FIGURE 1 | Scheme for CRD and EMG.
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in paraffin. The tissue block was sectioned at a thickness of
5-µm, and mounted on poly lysine coated slides. Six serial slides
were deparaffinized and rehydrated sequentially. Three slides
were stained with haematoxylin and eosin (H&E) and another
three stained with 0.5% toluidine blue. The slides were visualized
with the images under a light microscope (Nikon Eclipse 80I,
Nikon Corporation, and Tokyo, Japan) with a 20× objective lens.
Microscopic changes were blindly assessed by two investigators
using the scoring system on 0–9 scales as previously described
(Du et al., 2014). Mast cells were counted in three fields per
ileal section, and the average number of mast cells per field was
calculated.
CGRP Immunohistochemistry in DRG
The DRG fixed in 4% buffered formaldehyde was embedded in
paraffin. The tissue block was sectioned at a thickness of 4-µm,
and mounted on poly lysine coated slides. Four serial slides
were deparaffinized and rehydrated sequentially, followed by the
Streptavidin–Biotin Complex immunohistochemistry procedure
as follows. The serial slides were incubated with rabbit-anti-
CGRP (Abcam Inc., Cambridge, MA-02139-1517, USA; 1:100
diluted in PBS), and PBS (the negative control), respectively,
and, sequentially, for 24 h at 4◦C. Then, they were treated
with secondary antibodies (SA1022-anti-rabbit IgG Kit, Wuhan
Boster Biological Technology Ltd., Wuhan, China). Avidin-biotin
complex Staining (Wuhan Boster Biological Technology Ltd.,
Wuhan, China) was visualized with diaminobenzidine (DAB)
for 1 min at room temperature. All sections were dehydrated in
graded ethanol series, made transparent in xylene, coverslipped,
and air-dried. The slides were visualized with the images of the
stained areas under a light microscope (Nikon ECLIPSE 80I,
Nikon Corporation, and Tokyo, Japan), and 3 fields of each slide
were observed with a 20× objective lens. The numbers of CGRP
positive cells were counted with the Image-Pro plus 6.0 system
(Media Cybernetics, Inc., Bethesda, MD, USA). The mean values
calculated from three sections represented the CGRP positive
cells per rat.
Measurement of MPO and Cytokines
The ileal tissue was grinded and homogenized in 1 ml PBS,
pH 7.2 at 4◦C. The solution was centrifuged at 5000 g at 4◦C
for 10 min. The protein concentration of the supernatant was
determined using Nanodrop Spectrophotometer (Thermo Fisher
Scientific, Inc., USA). The MPO concentration was assayed
with MPO ELISA Kit (eBioscience, Inc., San Diego, CA 92121,
USA) according to the manufacturer’s instructions. Likewise, the
concentrations of TNF-α, IL-1β, and IL-6 were measured using
ELISA kits (NeoBioscience, China). Each sample was analyzed in
triplicate and the values were presented as pg/mg.
Statistical Analysis
All data were expressed as the mean± SD. Statistical analysis was
performed using SPSS version 18 (SPSS Inc., Chicago, IL, USA).
The statistical comparisons for parametric data (Body Weight,
CGRP, MPO, TNF-α, IL-1β, and IL-6) were carried out using
one-way analysis of variance (ANOVA) followed by Bonferroni
post hoc test (Dunnett’s T3 test was used if variables were
unequal). The statistical differences of non-parametric values
(DAI, macroscopic and microscopic scores, mast cells and VMR)
among groups were identified using Kruskal–Wallis ANOVA
followed by the rank-based Mann–Whitney U-test. The VMR at
20, 40, 60, 80, and 100 mmHg each for 6 s was added to calculate
the total VMR for 30 s. Correlation between total VMR and
CGRP level was assessed by computing Pearson’s P as correlation
coefficient. A difference was accepted as significant if P was less
than 0.05.
RESULTS
Symptom Observation and Disease
Activity Index
There were no difference (P > 0.05) in body weight between the
ethanol- or TNBS- rats and saline-rats at day 1. Compared with
the saline-rats, the body weight in the ethanol- or TNBS- treated
rats decreased (P= 0.031 or 0.001) at day 3 after the injection. But
the body weight of the TNBS group was not different (P > 0.05)
from that of the ethanol group at day 3. There was no difference
(P > 0.05) in the body weight among three groups during day
7 to 28 (Figure 2A). The TNBS- or Ethanol-administrated rats
displayed diarrhea, reduced grooming and sluggishness at day 1,
bloody diarrhea at day 2 to 5 after the treatment. The rats showed
normal fecal pellets at day 7. Compared with the saline group, the
rats of ethanol groups showed higher (P = 0.018 and 0.013) DAI
scores at day 1 and 3. The TNBS-treated rats showed increased
(P = 0.005 and 0.013) DAI scores as compared to the saline
group at day 1 and 3. There was no difference in the DAI scores
between TNBS group and ethanol group during the experiment
(Figure 2B).
Macroscopic Scoring of Ileitis
The macroscopic examination of ileum showed no apparent
change (P > 0.05) in the saline group during the experiment.
The ethanol-treated ileum showed erythema, mucosal necrosis
and edema in the injected segment of the terminal ileum at day 1,
but no significant morphological changes were observed at day
3 and thereafter. The TNBS-treated ileum revealed pathologic
changes as similar to the ethanol-treated ileum at day 1, and mild
erythema, mucosal necrosis, adhesion with cecum or mesentery,
ulcerations and the enteric wall thickness at day 3 and day 7, and
no obvious pathological changes at day 14 to 28 (Figure 2C). No
apparent change was observed in the adjacent intestinal segment
such as jejunum, cecum, and colon. As shown in Figure 2D,
no difference was found in the macroscopic scores between the
saline group and ethanol group. TNBS-treated ileums revealed
increased (P= 0.012) macroscopic scores as compared to ethanol
group at day 1. The macroscopic scores in TNBS group were
higher (P < 0.05) than those in the saline group at day 1 to 7.
There was no difference (P > 0.05) in the macroscopic scores
between the TNBS group and saline group at day 14 to 28.
Microscopic Scoring of Ileitis
The severity of inflammation was assessed according to
crypt architecture, inflammatory cell infiltration and ulceration
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FIGURE 2 | Effects of TNBS administration on body weights and macroscopic pathologic changes in rats. Body weight changes. ∗P < 0.05, TNBS group
vs. Saline group; ++P < 0.01, TNBS group vs. Ethanol group; One-way ANOVA followed by Bonferroni’s post-test (A). Scores of DAI ranging from 0 (healthy) to 12
(maximal severity of ileitis): body weight (0–4), stool consistency (0–4), and rectal bleeding (0–4) (B). Macroscopic pathologic changes at day 1,3,7,14,21, and 28
(C). Macroscopic change scores on a scale of 0–4 (D). ∗∗P < 0.01, ∗P < 0.05; TNBS group/Ethanol group vs. Saline group. +P < 0.05; TNBS group vs. Ethanol
group. Kruskal–Wallis analysis followed by Mann–Whitney U-test.
(Figures 3Aa,b,c). No apparent pathological changes were found
in saline-injected ileums during the experiment. The ethanol-
treated ileums revealed a moderate number of neutrophils in
the lamina propria, minimal or moderate interstitial wall edema,
reduced crypt depth, and decreased goblet cells while TNBS-
treated ileums showed shorter crypt, disordered villi, debris
of epithelium, and less goblet cells, neutrophils, lymphocytes,
granulomas and severe edema in the submucosa at day 1 to 14.
The pathological changes in the TNBS group abated at day 21,
and were not obviously observed at day 28. Compared with the
saline group, the ethanol-treated ileum showed higher (P < 0.05)
microscopic scores at day 1 to 14 while the TNBS-treated ileum
demonstrated increased microscopic scores (P < 0.01) at day 1
to 21. Compared with the ethanol group, the TNBS treatment
resulted in higher (P < 0.01) microscopic scores at day 7 to 21.
There was no difference (P > 0.05) in the microscopic score
among three groups at day 28 (Figure 3Ad).
Figures 3Ba,b,c represent the mast cells observed in the ileum
stained with toluidine blue at day 3. There were no differences
(P > 0.05) in mucosal mast cells among three groups at day 1
and day 14 to 28. Compared with the saline group, the ethanol
group showed more (P= 0.019) mucosal mast cells at day 3 while
the TNBS treatment resulted in increased (P = 0.01 and 0.008)
mucosal mast cells at day 3 and 7 (Figure 3Bd).
The Expression Levels of CGRP in the
DRG
The CGRP-IR cells in the DRG at day 14 have been shown in
Figures 4A–D. The CGRP expressions in the DRG of TNBS-
treated rats were higher than rats of saline or ethanol group.
There was no difference in CGRP-IR positive cells (P > 0.05)
among three groups at day 1 and 3. The CGRP-IR cells in
TNBS-treated rats increased by 2.06-fold (P < 0.05) and 1.68-
fold as compared to saline group and ethanol group, respectively,
at day 7. In TNBS-treated rats, the CGRP-IR positive cells
increased further and reached (P < 0.01) greatest, i.e., 5.56-fold
and 4.26-fold as compared to saline group and ethanol group,
respectively, at day 14. Thereafter, CGRP-IR positive cells in
TNBS treated rats decreased but remained 1.88-fold and 1.57-
fold higher (P < 0.01) as compared to saline group and ethanol
group, respectively, at day 21. There was no difference in CGRP-
IR positive cells (P > 0.05) among three groups at day 28
(Table 1).
Concentrations of MPO and Cytokines
There was no difference in MPO concentration between the
TNBS group and the ethanol group during the experiment.
The MPO concentration in the ileal tissue of the TNBS group
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FIGURE 3 | Effects of TNBS administration on histopathology of the ileum in rats. Microscopic changes of the ileum stained with hematoxylin and eosin (H&E)
(Aa–c). The microscopic change scores on a 0–9 scale, crypt architecture (0–3), inflammatory cell infiltration (0–3), and ulceration (0–3) (Ad). The morphological
changes of the ileum stained with toluidine blue (Ba–c). The number of the toluidine-blue-stained positive mucosal mast cells in the ileum (Bd). ∗∗P < 0.01,
∗P < 0.05; TNBS group/Ethanol group vs. Saline group. ++P < 0.01; TNBS group vs. Ethanol group. Kruskal–Wallis analysis followed by Mann–Whitney U-test.
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FIGURE 4 | Effects of TNBS administration on the expression levels of
CGRP in the DRG of the rats. Densities of GRP-IR cells in the DRG at day
14 (A–C). The negative control at day 14 (D).
increased (P < 0.01) at day 1 to 14 compared with the saline
group. Likewise, the TNBS-treated ileums showed (P = 0.005
and 0.01) elevated MPO concentration as compared to the
ethanol-treated rats at day 1 and 14. There was no difference
(P > 0.05) in MPO concentration among three groups at day 21
and 28 (Figure 5A).
As illustrated in Figures 5B–D, the ethanol group revealed
increased (P = 0.001) TNF-α concentration as compared to the
saline group at day 1. TNF-α concentration in the TNBS group
was higher (P < 0.05) at day 1, 3, and 7 compared with the saline
group, and higher (P= 0.000 and 0.005) at day 1 and 3 compared
with the ethanol group. No significant differences in TNF-α
concentration were observed (P > 0.05) among three groups
at day 14 to 28. Compared with the saline group, the TNBS-
treated rats showed increased (P < 0.05) IL-1β concentration
at day 1 to 14. The TNBS group revealed elevated (P < 0.05)
IL-1β concentration compared with the ethanol group at day
1, 7 and 14. The IL-1β concentration decreased (P > 0.05)
among three groups at day 21 and 28. The TNBS-treated ileum
revealed increased (P= 0.00, 0.001 and 0.002) IL-6 concentration
compared with the saline group at day 1, 3, and 7. Rats in
the TNBS group showed increased (P = 0.00 and 0.005) IL-6
concentration at day 1 and 3 compared with the ethanol rats.
There was no difference in IL-6 concentration (P > 0.05) among
three groups at day 14 to day 28.
Visceromotor Response to Colorectal
Distension
The EMG of abdominal muscles’ was recorded for assessment
of VH (Figures 6A–F). There was no change in the magnitude
of the VMR between the saline- and ethanol-treated rats during
the experiment. There was no difference (P > 0.05) in VMR
with 20, 40, 60, 80, and 100 mmHg CRD pressures among the
three groups at day 1 and 3. Compared with the saline rats, the
TNBS-treated rats demonstrated higher (P< 0.05) VMR with 60,
80 and 100 mmHg CRD pressures at day 7 to day 21. The rats
in the TNBS group demonstrated increased (P = 0.041) VMR
with 100 mmHg of CRD at day 14 compared with the ethanol
group. No difference (P > 0.05) was found in VMR with 20, 40,
60, 80, and 100 mmHg CRD pressures among the three groups
at day 28.
Correlation between Total VMR and
CGRP Level
In TNBS-treated rats, the total VMR did not correlate (P > 0.05)
with CGRP level at day 1 and 3. The correlations were observed
between total VMR and CGRP level in TNBS-treated rats at day
7(r = 0.740, P = 0.036), 14 (r = 0.789, P = 0.020), and 21
(r = 0.736, P = 0.037). No correlation (P > 0.05) was found
between total VMR and CGRP level in TNBS treatment at day
28 (Table 2).
DISCUSSION
Crohn’s disease is a chronic IBD that can occur in any part
of the gastrointestinal tract, but most frequently in the ileum.
Currently the understanding of the mechanism underlying
hypersensitivity of CD has been seriously hindered by a lack of
animal models that faithfully resemble this disease of humans.
A few researchers have used TNBS to induce ileal inflammation
for physiological and pharmacological studies. O’Hara et al.
(2007) injected TNBS (0.5 ml; 30 mg/ml in 30% ethanol) into
the ileum of guinea pigs and observed a severe inflammation at
3 days. Moreels et al. (2001) injected 30 mg TNBS (dissolved
in 0.25 ml of 40% ethyl alcohol) into rats’ ileum and found
a marked inflammatory reaction occurred at 36 h and lasted
up to 7 days. Nurgali et al. (2007, 2011) and Pontell et al.
(2009) administered TNBS (30 mg/kg body weight in 1 ml
of 30% ethanol) into the ileum of guinea pigs and observed
the clinically as well as histologically inflammatory evidences
TABLE 1 | Effects of TNBS administration on CGRP-immunoreactivities expression in DRG of rats.
Group Days
1 3 7 14 21 28
Saline 10.78 ± 3.29 14.27 ± 6.97 13.64 ± 5.08 11.18 ± 2.27 11.09 ± 1.82 9.74 ± 1.12
Ethanol 12.67 ± 4.95 16.59 ± 0.46 16.73 ± 8.92 14.61 ± 3.61 13.26 ± 2.36 9.95 ± 0.76
TNBS 16.54 ± 2.61 19.87 ± 5.18 25.52 ± 2.01a 44.02 ± 7.73AB 21.48 ± 2.22AB 11.28 ± 0.66
Data are expressed as Mean ± SD. AP < 0.01 and aP < 0.05 represents significant difference between TNBS group and Saline group. BP < 0.01 represents significant
difference between TNBS group and Ethanol group. One-way ANOVA followed by Dunnett’s T3 post-test.
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FIGURE 5 | Effects of TNBS administration on the levels of MPO (A), TNF-α (B), IL-1β (C), and IL-6 (D) in the ileal tissue of the rats. ∗∗P < 0.01,
∗P < 0.05; TNBS group/Ethanol group vs. Saline group. ++P < 0.01, +P < 0.05; TNBS group vs. Ethanol group. (TNBS vs. Ethanol/Saline group; One-way ANOVA
followed by Dunnett’s T3 post-test) (Ethanol group vs. Saline group; One-way ANOVA followed by Bonferroni’s post-test).
up to 7 days. These studies showed a short duration of ileitis
induced by TNBS. Shibata et al. (1993) injected 1 g TNBS
(dissolved in 20 ml in 50% ethanol) into canine ileum, and
induced severe mucosal lesions characterized by extensive ulcers
and granulomas and lymphocyte infiltration for 2 months. It
is seen that the severity and duration of TNBS-induced ileitis
are dose- and concentration- dependent. In the present study,
80 mg/kg body weight TNBS in 30% ethanol caused weight loss,
lethargies and bloody diarrhea, and histopathologically apparent
changes characterized by hemorrhagic foci, mucosal necrosis,
granulomas, distorted villi, diffuse infiltration of neutrophils and
lymphocytes in lamina propia, and thickened ileal wall in rats.
These symptoms and pathological changes in our study are
similar to the macroscopic and microscopic findings observed
in human CD. According to DAI scores, macroscopic, and
microscopic changes, the TNBS-induced ileitis in our experiment
occurred at 3 days, reached maximum at 7 days, persisted
up to 3 weeks and healed spontaneously at 4 weeks. This
dose and concentration of TNBS was found to be suitable for
inducing subacute and chronic ileitis in rats. Besides, some
other factors may also be responsible for discrepancies in
pathological changes of TNBS-induced ileitis. Intestine emptying
and peristalsis can reduce the contact time of TNBS with the
ileal mucosa. Merritt et al. (2002) administered 0.5–1 g TNBS
(dissolved in 33 to 75% ethanol) to porcine ileum with or
without it confined to the lumen, and observed significant
multifocal necrosis and ulceration in the pigs with the instillate
was confined to the distal ileum, but did not in the pigs
in which the instillate was not held within an ileal segment.
The study of Merritt et al. (2002) did not show the resultant
pathological changes because their experiment ended at day 7.
We milked free of the gut content, occluded approximate ileal
fragment with thumb and forefingers for 5 min to confine the
injected TNBS solution. The TNBS injection induced apparent
ileal lesions for 21 days. Granulomas are features of CD
and have been described in approximately 50% of rats with
TNBS colitis. Epidemiology suggests some relationship between
the establishment of gut flora and the risk of developing
inflammatory granulomas. In animal model, broad-spectrum
antibiotics reduce the bacterial load and militate against gut
inflammation. Brenna et al. (2013) found that TNBS solution
(0.6 ml; 30 mg/ml in 50% ethanol) did not induce granuloma
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FIGURE 6 | Effects of TNBS administration on VH, measured by EMG of abdominal muscles’ VMR to CRD pressure. Representative EMG traces and
VMR to CRD at day 1 (A), 3 (B), 7 (C), 14 (D), 21 (E), and 28 (F). ∗∗P < 0.01, ∗P < 0.05; TNBS group/Ethanol group vs. Saline group. +P < 0.05; TNBS group vs.
Ethanol group. Kruskal–Wallis analysis followed by Mann–Whitney U-test.
in colonic mucosa of rats at 12 days after TNBS administration,
and attributed it to the intestinal bacterial reduction due to the
sterile animal housing facilities. The granuloma development
in the present study may be due to a certain number of
microorganisms existing in the ileum (Duval-Araujo et al., 2007)
and the possibility of their proliferation under the pathological
condition.
Several studies have shown that patients with IBD
demonstrate abdominal hypersensitivity to nociceptive stimuli
applied to visceral tissues, and that there is discrepancy between
the intensity of gastrointestinal symptoms such as pain or
discomfort and the severity of mucosal lesions. Some animal
models have developed inflammatory lesions in the ileum that
are similar to human CD (Tanaka and Sugie, 2013). However, no
any studies confirm whether or not VH exists. Adam et al. (2006)
investigated various degrees (mild, moderate, and severe) of
colitis induced by different concentrations (0.2, 0.4, and 0.8 ml;
5 mg/kg body weight in 50% ethanol) of TNBS, and observed
the resultant visceral hyperalgesia through assessment of VMR
to the mechanical CRD. They found that visceral hyperalgesia
and its intensity are inflammation-severity dependent; moderate
and severe inflammations (mild inflammation with repeated
colorectal distention) evoked visceral hyperalgesia. Therefore,
severity of mucosal inflammation could be used as a predictor
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TABLE 2 | The correlation between CGRP level in DRG and total VMR in
TNBS-treated rats.
Days CGRP-IR Total VMR (30 s) Correlation
coefficient
Significant
level
1 16.54 ± 2.61 46.60 ± 10.80 r = 0.348 P = 0.398
3 19.87 ± 5.18 93.73 ± 18.13 r = 0.224 P = 0.593
7 28.22 ± 3.40 87.17 ± 21.33 r = 0.740∗ P = 0.036
14 62.27 ± 5.14 93.08 ± 22.20 r = 0.789∗ P = 0.020
21 20.85 ± 3.16 87.17 ± 21.33 r = 0.736∗ P = 0.037
28 11.28 ± 0.66 85.02 ± 25.77 r = 0.325 P = 0.431
Data are expressed as Mean ± SD. ∗Pearson correlation between CGRP-IR and
total VMR is significant at the 0.05 level (2-tailed).
for alterations of visceral sensory function. Several studies
(Traub, 2000; Kyloh et al., 2011) indicated that the VH from the
rectum is mediated via both thoracolumbar and lumbosacral
spinal afferents pathways, whereas VH from upper colon or
ileum is primarily mediated via thoracolumbar spinal afferents
pathways. Because there is a convergence of nociceptive afferents
from small and large intestines on the spinal neurons, CRDs
can be used as stimuli to assess VH produced in TNBS-ileitis.
In the present study, the rats with ileitis exhibited significant
VMR to CRD at day 7 to day 21, demonstrating that VH did
accompany TNBS-induced ileitis. The hypersensitivity reactions
observed in this study might be evoked due to sensitization of
both thoracolumbar and lumbosacral spinal afferents pathways,
because the TNBS injection into the terminal ileum played role
for sensitization of the thoracolumbar spinal afferents, while
CRD resulted sensitization effects on the lumbosacral spinal
afferents.
Mucosal mast cells are located in close proximity to the
enteric sensory nerves throughout the gut and their activation
or degranulation in response to stimuli release inflammatory
mediators that can excite the sensory nerves (Stevens and Austen,
1989; Bueno et al., 1997). Ohashi et al. (2008) injected TNBS
(50 mg/1.5 ml/kg body weight) into the colon of wild rats
and mast cell knockout rats, and reported mucosal necrosis,
extensive inflammatory cells infiltration in colonic mucosa of
both wild rats and mast cell knockout rats. Interestingly, the
TNBS-treated wild rats revealed VH but mast cells knockout
rats failed to elicit VH in response to CRD. In the current
experiment, the ileal mucosal mast cells increased in TNBS-
or ethanol-treated rats at day 3 and in TNBS-treated rats at
day 7, which resembles the markedly increased ileal mucosal
mast cells in CD patients (Gelbmann et al., 1999). Studies
showed that in biopsies obtained from patients with IBDs, the
number of inflammatory and immune cells (e.g., mast cells,
neutrophils, T-lymphocytes, and macrophages) were increased,
and thereby activated inflammatory cells resulted in a release
of certain mediators such as cytokines, proteases, etc., which
affected the secreto-motor response of the gut and abnormal
bowel functions (Weston et al., 1993; Chadwick et al., 2002;
Barbara et al., 2004). MPO is mainly present in neutrophils
and its oxidative products are involved in numerous processes
of tissue damage in inflammatory pathology. In the TNBS-
induced ileitis, MPO concentration was reported to increase
during acute phase of the inflammation. In our study, it was
increased at day 1 to day 14, which is similar to the previous
report (Martinolle et al., 1997). It has been demonstrated that
inflammatory cytokines have a critical role in the development
of VH. In IBD and experimental colitis, monocytes in blood
are recruited to the mucosa and differentiate into activated
macrophages that produce proinflammatory cytokines, such as
TNF-α, IL-1β, and IL-6 (Maloy and Powrie, 2011; Bain et al.,
2013). It was reported that peripheral blood mononuclear cells
from diarrhea-predominant IBS patients displayed elevated levels
of TNF-α, IL-1β, and IL-6 (Liebregts et al., 2007). Adam et al.
(2006) measured the serum IL-6 level in rats with TNBS-induced
colitis, and found that the increased serum IL-6 was associated
with increased VMR to CRD. However, the relationship between
cytokine levels in inflamed ileal tissues and hypersensitivity has
not been reported. In our study, TNF-α and IL-6 concentrations
markedly increased at day 1 to 7 while IL-1β concentration was
upregulated at 1 to 14 days. The three cytokines reached their
peak levels at day 1 to day 3, which was earlier than the ileitis
at day 7 and the VH at day 14. These findings ascertain the
role of TNF-α, IL-6, and IL-1β in the initiation and maintenance
of the ileitis and the VH. In present study, the increased VMR
to graded CRD (20–100 mmHg) did not correlate with ileal
IL-6 level (data not shown). Adam et al. (2006) reported that
different concentrations of TNBS (0.4 and 0.8 ml; 5 mg/kg
body weight) induced a moderate colitis followed by a biphasic
change of visceral hyperalgesia in rats; the hyperalgesia was
observed at day 3, but disappeared at day 14, and occurred
again at day 28 to day 42 after TNBS administration. Feng
et al. (2012) used TNBS (0.2 ml, 200 mg/kg body weight),
intracolonally and observed severe colitis followed by significant
VMR to CRD at day 7 to 14. The discrepancy in onset time
and duration of VH between the reports by Adam et al. (2006)
and Feng et al. (2012) may be due to different doses of TNBS.
In our experiment, we found that TNBS (0.6 ml, 80 mg/kg
body weight) induced a moderate ileitis and VH occurred at
day 7 to 21, which is similar to the report by Feng et al.
(2012).
Bernstein et al. (1996) presented the evidence of reduced
sensitivity and autonomic reflex responses to rectal distension in
ileal CD patients. Chang et al. (2000) reported that the colonic
hypersensitivity is generally absent in patients either with UC
in quiescent or mildly active phases of the IBDs. However,
a study of Faure and Giguere (2008) in small population of
pediatric CD patients coexisting functional GI disorders reported
rectal hypersensitivity in 87.5% CD patients with low rectal
sensory thresholds for pain compared with healthy controls. This
discrepancy may be due to region-specific degree or duration
of bowel inflammation. Annahazi et al. (2009) infused fecal
supernatants from diarrhea-predominant IBS and UC patients
into the colon of mice and demonstrated VH due to release
of serine-protease (activator of protease activated receptor-2,
PAR-2) and hyposensitivity because of released cathepsin-G
(activator of PAR-4), respectively. Further explanation for the
visceral sensitivity in CD could involve central sensitization
(Bernstein et al., 2002; Van Oudenhove et al., 2004) or descending
bulbospinal inhibition of sacral dorsal horn neurons in response
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to chronic intestinal tissue irritation (Bernstein et al., 1996). In
our experiment, VH resolved in TNBS-treated rats at day 28,
which may be caused by compensatory inhibitory mechanisms,
counteracting VH.
Although the causes of VH are known to include
some triggering events such as inflammation, trauma, or
environmental stress, little is known about the mechanism
underlying VH. TNBS-Ethanol combination works to cause
tissue damage and induce intestinal inflammatory cell
infiltration, release MPO, tryptase resulting activation of PAR-
2, and cytokines (TNF-α, IL-6, IL-1β, etc.) in the compromised
intestinal tissues. The interaction of these cytokines with
inflammatory cells, mast cell, lymphocytes, and enteric plexuses
sensitizes nociceptive afferent nerve terminals that are distributed
to the ileum. PAR-2 activation leads to sensitization of transient
receptor potential vanilloid subtype-1 receptors and triggers the
release of SP and CGRP (Adam et al., 2006). Several studies
highlighted the CGRP involvement in the visceral pain models
(Friese et al., 1997; Plourde et al., 1997; Gschossmann et al.,
2001). It has been reported that there is a remarkable change
in expression of SP and CGRP in response to inflammation
within DRG neurons as well as spinal neurons (Miampamba and
Sharkey, 1998; Suckow and Caudle, 2009), which ultimately play
an important role in neurogenic inflammation and hyperalgesia
(Gschossmann et al., 2001; Sun et al., 2004). In this study, TNBS
treatment remarkably increased the CGRP expressions in the
DRG of rats at day 7 to 21, which correlated with the VH.
Sustained depolarization of the nerve terminals would prolong
firing, resulting in increased afferent traffic to the specific neurons
in the spinal cord where excitatory signals are transmitted by the
relay neurons to the higher central nerve system (Moore et al.,
2002). Therefore, our model is useful to study the specific central
regulating mechanism underlying VH caused by the ileitis. The
VH maintained at a stable and continuous level in this study,
which will be beneficial for studying the specific central regulating
mechanism underlying VH caused by the ileitis.
CONCLUSION
2,4,6-trinitrobenzene sulfonic acid injection into the terminal
ileum caused weight loss, lethargies and bloody diarrhea and,
successfully induced transmural ileitis supported by pathological
changes and the releases of cytokines in rats, which is similar
to human CD. The significantly increased CGRP expressions
level in DRG correlated with increased VMR to CRD in TNBS-
induced ileitis at day 7 to 21, which unravels the existence of VH.
These data suggest its potentiality to probe into the pathogenesis
of inflammatory ileal diseases and VH as well as for evaluating
the effectiveness of new therapeutic agents.
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